Inhibrx Biosciences, Inc.
Ticker: INBX
| Insider | Title |
|---|---|
| Brendan P. Eckelman | Chief Scientific Officer |
| David C. Ott | 10% or greater ownership |
| Douglas Forsyth | Director |
| Global Investors Lp Viking | 10% or greater ownership |
| Global Opportunities Gp Llc Viking | 10% or greater ownership |
| Global Opportunities Illiquid Investments Sub-master Lp Viking | 10% or greater ownership |
| Global Opportunities Parent Gp Llc Viking | 10% or greater ownership |
| Global Opportunities Portfolio Gp Llc Viking | 10% or greater ownership |
| Inc. Inhibrx, | 10% or greater ownership |
| Jon Faiz Kayyem | Director |
| Kelly Deck | Chief Financial Officer |
| Kimberly Manhard | Director |
| Kristiina Md Vuori | Director |
| Mark Lappe | Chief Executive Officer, Director |
| Ole Andreas Halvorsen | 10% or greater ownership |
| Rose Sharon Shabet | 10% or greater ownership |